NYSEMKT: OSTX
Os Therapies Inc Stock Ownership - Who owns Os Therapies?

Insider buying vs selling

Have Os Therapies Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OSTX insiders and whales buy or sell their stock.

OSTX Shareholders

What type of owners hold Os Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shalom Auerbach5.83%2,687,570$4.78MInsider
Paul A. Romness4.87%2,248,000$4.00MInsider
John Ciccio0.99%455,835$811.39kInsider
Theodore F. Search0.99%455,835$811.39kInsider
Colin Goddard0.49%225,179$400.82kInsider
Robert Petit0.43%200,000$356.00kInsider
Christopher P. Acevedo0.24%109,375$194.69kInsider
Avril Suzette McKeandieser0.01%5,000$8.90kInsider
Vangrd0.00%778$1.38kInstitution
Vanguard Capital Management LLC0.00%777$1.38kInstitution

1 of 3

OSTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OSTX0.01%13.85%
FBIO0.02%49.61%Net Buying
ALDX0.06%28.23%Net Buying
CNTB0.02%22.08%Net Buying
VRCA0.02%99.98%Net BuyingNet Buying

Os Therapies Stock Ownership FAQ

Who owns Os Therapies?

Os Therapies (NYSEMKT: OSTX) is owned by 0.01% institutional shareholders, 13.85% Os Therapies insiders, and 86.15% retail investors. Shalom Auerbach is the largest individual Os Therapies shareholder, owning 2.69M shares representing 5.83% of the company. Shalom Auerbach's Os Therapies shares are currently valued at $4.70M.

If you're new to stock investing, here's how to buy Os Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.